A web-accessible complete transcriptome of normal human and DMD muscle

Neuromuscular Disorders

Volumn 12, Issue , 2002, Pages S125-S141

  Bakay, Marina ^a   Zhao, Po ^a   Chen, Josephine ^a   Hoffman, Eric P ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Duchenne muscular dystrophy muscle; Normal human muscle; Web accessible complete transcriptome

Indexed keywords

ACTIN; ANKYRIN; CONNEXIN 43; DYSTROPHIN; PROTEIN; PROTEIN CASQ2; PROTEIN CUGBP2; PROTEIN DERIVATIVE; PROTEINASE; RNA; RNA BINDING PROTEIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN BINDING PROTEIN 7; SOMATOMEDIN C; TROPONIN T; UNCLASSIFIED DRUG;

AUTOSOMAL INHERITANCE; CHILD; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DATA BASE; DNA MICROARRAY; DUCHENNE MUSCULAR DYSTROPHY; EXPRESSED SEQUENCE TAG; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE PROBE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HEART; HUMAN; HUMAN TISSUE; INTERNET; MACROPHAGE; MALE; MUSCLE REGENERATION; MYOBLAST; PREDICTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; REGULATORY MECHANISM; RNA ANALYSIS; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; UPREGULATION; Y CHROMOSOME;

ANIMALS; BIOPSY; CHILD; CHILD, PRESCHOOL; DYSTROPHIN; GENE EXPRESSION PROFILING; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCLES; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA PROBES; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 0036823748     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(02)00093-7     Document Type: Article

References (38)

1. Hoffman E.P. Dystrophinopathies. Karpati G., Hilton-Jones D., Griggs R.C. Disorders of voluntary muscle. 7th ed. 2001;385-432 Cambridge University Press, New York.
2. Chen Y., Zhao P., Borup R., Hoffman E.P. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol. 151:2000;1321-1336.
3. Tseng B.S., Zhao P., Pattison J.S., et al. Regenerated mdx mouse skeletal muscle shows differential mRNA expression. J Appl Physiol. 2002;. in press.
4. Lanfranchi G., Muraro T., Caldara F., et al. Identification of 4370 expressed sequence tags from a 3′-end-specific cDNA library of human skeletal muscle by DNA sequencing and filter hybridization. Genome Res. 6:1996;35-42.
5. Hoffman E.P., Fischbeck K.H., Brown R.H., et al. Dystrophin characterization in muscle biopsies from Duchenne and Becker muscular dystrophy patients. N Engl J Med. 318:1988;1363-1368.
6. Lockhart D.J., Dong H., Byrne M.C., et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol. 14:1996;1675-1680.
7. Bakay M., Chen Y., Borup R., Zhao P., Nagaraju K., Hoffman E.P. Sources of variability and effect of experimental approach on expression profiling data interpretation. BMC Bioinformatics. 3:2002;4-15.
8. GeneSpring User Manual, version 4.0, March 2001, Silicon Genetics.
9. GeneSpring Advanced Analysis Techniques, version 4.0, March 2001, Silicon Genetics.
10. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 95:1998;14863-14868.
11. Tezak Z., Hoffman E.P., Lutz J.L., et al. Gene expression profiling in DQA1*0501(+) children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol. 168:2002;4154-4163.
12. Fischer M.D., Gorospe J.R., Felder E., et al. Expression profiling reveals metabolic and structural components of extraocular muscle. Physiol Genomics. 2002;. in press.
13. Bellefroid E.J., Marines J.C., Matera A.G., et al. Emergence of the ZNF91 Kruppel-associated box-containing zinc finger gene family in the last common ancestor of Anthropoidea. Proc Natl Acad Sci USA. 92:1995;10757-10761.
14. Smith J., Goldsmith C., Ward A., LeDieu R. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death. Cell Death Differ. 7:2000;1109-1118.
15. Granchelli J.A., Pollina C., Hudecki M.S. Pre-clinical screening of drugs using the mdx mouse. Neuromusc Disord. 10:2000;235-239.
16. Lynch G.S., Cuffe S.A., Plant D.R., Gregorevic P. IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice. Neuromusc Disord. 11:2001;260-268.
17. Barton E.R., Morris L., Musaro A., Rosenthal N., Sweeney H.L. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol. 157:2002;137-148.
18. Yakar S., Liu J.L., Fernandez A.M., et al. Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes. 50:2001;1110-1118.
19. Fedele M.J., Lang C.H., Farrell P.A. Immunization against IGF-I prevents increases in protein synthesis in diabetic rats after resistance exercise. Am J Physiol Endocrinol Metab. 280:2001;E877-E885.
20. Bamman M.M., Shipp J.R., Jiang J., et al. Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans. Am J Physiol Endocrinol Metab. 280:2001;E383-E390.
21. Awede B.L., Thissen J.P., Lebacq J. Role of IGF-I and IGFBPs in the changes of mass and phenotype induced in rat soleus muscle by clenbuterol. Am J Physiol Endocrinol Metab. 282:2002;E31-E37.
22. Li Y.P., Reid M.B. Effect of tumor necrosis factor-alpha on skeletal muscle metabolism. Curr Opin Rheumatol. 13:2001;483-487.
23. Lang C.H., Nystrom G.J., Frost R.A. Tissue-specific regulation of IGF-I and IGF-binding proteins in response to TNFalpha. Growth Horm IGF Res. 11:2001;250-260.
24. Anwar A., Zahid A.A., Scheidegger K.J., Brink M., Delafontaine P. Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle. Circulation. 105:2002;1220-1225.
25. Foulstone E.J., Meadows K.A., Holly J.M., Stewart C.E. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis. J Cell Physiol. 189:2001;207-215.
26. Hoeflich A., Nedbal S., Blum W.F., et al. Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. Endocrinology. 142:2001;1889-1898.
27. Zhang M., Smith E.P., Kuroda H., Banach W., Chernausek S.D., Fagin J.A. Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice results in IGFBP-4 stabilization and smooth muscle hypotrophy. J Biol Chem. 2002;. in press.
28. Jennische E., Hall C.M. Expression and localisation of IGF-binding protein mRNAs in regenerating rat skeletal muscle. APMIS. 108:2000;747-755.
29. Melone M.A., Peluso G., Galderisi U., Petillo O., Cotrufo R. Increased expression of IGF-binding protein-5 in Duchenne muscular dystrophy (DMD) fibroblasts correlates with the fibroblast-induced downregulation of DMD myoblast growth: an in vitro analysis. J Cell Physiol. 185:2000;143-153.
30. Kuemmerle J.F., Zhou H. IGFBP-5 stimulates growth and IGF-I secretion in human intestinal smooth muscle by Ras-dependent activation of p38 MAP kinase and Erk1/2 pathways. J Biol Chem. 2002;. in press.
31. Apple F.S., Ricchiuti V., Voss E.M., Anderson P.A., Ney A., Odland M. Expression of cardiac troponin T isoforms in skeletal muscle of renal disease patients will not cause false-positive serum results by the second generation cardiac troponin T assay. Eur Heart J. 19:1998;N30-N33.
32. Ricchiuti V., Apple F.S. RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. Clin Chem. 45:1999;2129-2135.
33. Messner B., Baum H., Fischer P., Quasthoff S., Neumeier D. Expression of messenger RNA of the cardiac isoforms of troponin T and I in myopathic skeletal muscle. Am J Clin Pathol. 114:2000;544-549.
34. Hammerer-Lercher A., Erlacher P., Bittner R., et al. Clinical and experimental results on cardiac troponin expression in Duchenne muscular dystrophy. Clin Chem. 47:2001;451-458.
35. Timchenko L.T., Miller J.W., Timchenko N.A., et al. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 15:1996;4407-4414.
36. Philips A.V., Timchenko L.T., Cooper T.A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science. 28:1998;737-741.
37. Good P.J., Chen Q., Warner S.J., Herring D.C. A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator. J Biol Chem. 275:2000;28583-28592.
38. Anant S., Henderson J.O., Mukhopadhyay D., et al. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor. J Biol Chem. 276:2001;47338-47351.